ClearPoint Neuro, Inc. (CLPT) Guidance & Earnings Results

On 2026-08-03 ClearPoint Neuro, Inc. lowered guidance: "Full-year 2026 revenue guidance adjusted to $48-52M (midpoint…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CLPTClearPoint Neuro, Inc.Follow CLPT — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 278.8M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 28 Oct, in 4 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
3 Aug 26	Lowered	Full-year 2026 revenue guidance adjusted to $48-52M (midpoint $50M). · full year
13 May 26	Raised	Revenue guidance $52M-$56M for FY2026 · full year
17 Mar 26	Raised	FY2026 revenue guidance $52-56M vs FY2025 $37M; ~46% growth at midpoint
12 Jan 26	Raised	FY2026 revenue guidance of $54-60M vs FY2025 revenue of $37M
6 Nov 25	Reaffirmed	FY2025 revenue range $36.0M to $38.0M · full year
12 Aug 25	Reaffirmed	FY2025 revenue outlook $36.0-41.0 million · full year

ClearPoint Neuro, Inc. — questions

What guidance did ClearPoint Neuro, Inc. give?: On 2026-08-03: "Full-year 2026 revenue guidance adjusted to $48-52M (midpoint $50M)."
When does ClearPoint Neuro, Inc. report earnings?: ClearPoint Neuro, Inc.'s next earnings report is expected on 2026-10-28.

Every figure on this page comes from ClearPoint Neuro, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.